Hemodialysis EPO Injection – 4000 IU
Hemodialysis EPO Injection – 4000 IU is used to stimulate red blood cell production in patients undergoing dialysis. It helps manage anemia caused by chronic kidney disease. The injection is sterile, ready-to-use, and safe for administration under medical supervision.
Advin Health Care offers the Hemodialysis EPO Injection – 4000 IU, formulated to effectively treat anemia in patients receiving hemodialysis. This recombinant erythropoietin therapy promotes red blood cell production, enhancing oxygen transport and patient energy levels. Produced under strict medical-grade standards, the injection is sterile and suitable for intravenous or subcutaneous use. Its precise dosing ensures consistent therapeutic effect, reducing the need for frequent blood transfusions and supporting optimal anemia management in dialysis patients.
Advanced Features:
- Recombinant erythropoietin for red blood cell stimulation
- Helps manage anemia in chronic kidney disease patients
- Sterile, ready-to-use injection for safe administration
- Suitable for intravenous or subcutaneous use
- Precise dosing ensures consistent therapeutic effect
- Manufactured under strict medical-grade standards
Product Also Known As:
EPO Injection 4000 IU, Hemodialysis Erythropoietin Injection, Dialysis Anemia Injection, Recombinant Erythropoietin for Dialysis, Dialysis RBC Stimulator, Hemodialysis Anemia Therapy, Dialysis EPO Injection, Erythropoietin Therapy Injection
